Your browser doesn't support javascript.
loading
The action of decorin in anti-fibrosis and anti-cancer / 生物医学工程学杂志
Article in Zh | WPRIM | ID: wpr-331360
Responsible library: WPRO
ABSTRACT
Decorin (DCN) is a member of the small leucine-rich proteoglycan gene family. Many studies indicated that DCN inhibited fibrosis and scar-formation by neutralization of TGF-P and interfering the binding of TGF-beta with its receptor, which induced ectopic deposition of extracellular matrix. Additionally, DCN can prevent the proliferation and metastasis of tumor cells by activating EGFR/MAPK/p21 signal pathway and inhibiting the cell proliferation pathway mediated by EGF-EGFR. It is suggested that the recombinant DCN had potential pharmaceutical potency in treatment of chronic fibrosis and neoplasm for its critical biological activities and low immunogenicity.
Subject(s)
Full text: 1 Index: WPRIM Main subject: Pharmacology / Proteoglycans / Fibrosis / Recombinant Proteins / Chemistry / Extracellular Matrix Proteins / Transforming Growth Factor beta1 / Decorin / ErbB Receptors / Antineoplastic Agents Limits: Animals / Humans Language: Zh Journal: Journal of Biomedical Engineering Year: 2007 Type: Article
Full text: 1 Index: WPRIM Main subject: Pharmacology / Proteoglycans / Fibrosis / Recombinant Proteins / Chemistry / Extracellular Matrix Proteins / Transforming Growth Factor beta1 / Decorin / ErbB Receptors / Antineoplastic Agents Limits: Animals / Humans Language: Zh Journal: Journal of Biomedical Engineering Year: 2007 Type: Article